PHILIP DY, M.D.
Medical Oncology Physician · EFFINGHAM, IL
Individual Active NPI 1710076567
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,147 | 753,539 | $42,198,108 | $13,878,377 | $11,064,096 |
| 2023 | 1,195 | 652,864 | $39,142,183 | $12,655,088 | $10,078,638 |
| 2022 | 1,139 | 658,668 | $38,015,206 | $12,156,331 | $9,703,345 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 231,000 | $1 | $1 |
| J9271 | Injection, pembrolizumab, 1 mg | 39,600 | $56 | $45 |
| J9299 | Injection, nivolumab, 1 mg | 29,800 | $31 | $25 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 28,500 | $0 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 26,600 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 22,860 | $49 | $39 |
| J0185 | Injection, aprepitant, 1 mg | 19,630 | $2 | $1 |
| J9267 | Injection, paclitaxel, 1 mg | 14,878 | $0 | $0 |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 14,431 | $8 | $6 |
| J0897 | Injection, denosumab, 1 mg | 12,720 | $26 | $21 |
| J1930 | Injection, lanreotide, 1 mg | 12,240 | $48 | $39 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 8,830 | $45 | $36 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 036097243 | IL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Illinois
- NPI 1295211373
- NPI 1013273614
- NPI 1225314362
- NPI 1326525114
- NPI 1043283849
- NPI 1891761532
- NPI 1457989873
- NPI 1134448665
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.